https://orcid.org/0000-0002-3759-1508
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Renato Vellucci & Diego Fornasari. (2023) Appropriate use of tapentadol: focus on the optimal tapering strategy. Current Medical Research and Opinion 39:1, pages 123-129.
Read now
Read now
Rainer Freynhagen, Ralf Baron, Yoshiharu Kawaguchi, Rayaz A. Malik, Diane L. Martire, Bruce Parsons, Roberto D. Rey, Stephan A. Schug, Troels Staehelin Jensen, Thomas R. Tölle, Takahiro Ushida & Ed Whalen. (2021) Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgraduate Medicine 133:1, pages 1-9.
Read now
Read now
Articles from other publishers (10)
Mark Obermann & Zaza Katsarava. (2024) Headache Attributed to a Substance or Its Withdrawal. Neurologic Clinics 42:2, pages 497-506.
Crossref
Crossref
Ashley Wang, Jasper Murphy, Lana Shteynman, Neil Daksla, Abhishek Gupta & Sergio Bergese. (2023) Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review. Pharmaceuticals 17:1, pages 29.
Crossref
Crossref
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
Jason W. Boland. (2023) Tapentadol for the management of cancer pain in adults: an update. Current Opinion in Supportive & Palliative Care 17:2, pages 90-97.
Crossref
Crossref
Friedhelm Sandbrink, Jennifer L. MurphyMelanie Johansson, Juli L. Olson, Ellen Edens, Jamie Clinton-LontJames Sall, Christopher SpevakFriedhelm Sandbrink, Jennifer L. Murphy, Melanie Johansson, Christopher Spevak, Jamie Clinton-Lont, Ellen Edens MD, Juli L. Olson, Nicole Brown, Raquel Guinta, Franz Macedo, Mitchell Nazario, Sanjog Pangarkar, Samuel Preston, Matthew Prince, Donna Endsley Real, David Riegleman, Evan Steil, ECRI Institute, Lewin Group & Sigma Health Consulting. (2023) The Use of Opioids in the Management of Chronic Pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine 176:3, pages 388-397.
Crossref
Crossref
Celina G. Virgen, Neil Kelkar, Aaron Tran, Christina M. Rosa, Diana Cruz-Topete, Shripa Amatya, Elyse M. Cornett, Ivan Urits, Omar Viswanath & Alan David Kaye. (2022) Pharmacological management of cancer pain: Novel therapeutics. Biomedicine & Pharmacotherapy 156, pages 113871.
Crossref
Crossref
Elizabeth Farrer & Andrew Dickman. (2022) New analgesics in cancer pain. Current Opinion in Supportive & Palliative Care 16:2, pages 60-64.
Crossref
Crossref
Andrew A Somogyi, Stefan T Musolino & Daniel T Barratt. (2022) New pharmacological perspectives and therapeutic options for opioids: Differences matter. Anaesthesia and Intensive Care 50:1-2, pages 127-140.
Crossref
Crossref
Aina Perelló-Bratescu, Christian Dürsteler, Maria Asunción Álvarez-Carrera, Laura Granés, Belchin Kostov & Antoni Sisó-Almirall. (2022) Trends in the Prescription of Strong Opioids for Chronic Non-Cancer Pain in Primary Care in Catalonia: Opicat-Padris-Project. Pharmaceutics 14:2, pages 237.
Crossref
Crossref
R.R. Sarmanaeva, G.R. Abuzarova, E.V. Gameeva, Yu.V. Brazhnikova & S.V. Kuznetsov. (2022) Clinical example of long-term opioid therapy with tapentadol for chronic pain in oncology. Onkologiya. Zhurnal imeni P.A.Gertsena 11:1, pages 55.
Crossref
Crossref